Risks & Benefits of Private Equity in Healthcare

Syllabus

1. Lesson 1: The Shifting Landscape of Medical Practice: Why Private Equity Arrived — and Why Every Physician Should Understand It (24 min)

   • Describe how the economics of medical practice have shifted over the past two decades.
   • Name the forces — costs, reimbursement, regulation, consolidation — pushing practices toward outside capital.
   • Frame private equity as a genuine trade-off, with benefits and risks we'll quantify across the course.

   Takeaway: Private equity didn't appear by accident — it walked through a door that economics opened. Rising costs, falling reimbursement, regulation, and consolidation have squeezed the independent practice, while healthcare's growth toward a third of the economy pulled capital in. Private equity is neither villain nor savior; it's a trade-off between capital and scale on one side and income, debt, and autonomy on the other. The job of this course is to make you literate enough to price that trade yourself.

2. Lesson 2: Costs & Reimbursements: a Practice P&L: What It Costs to Keep a Surgeon Working — and What's Left (20 min)

   • List the major cost lines that keep a single surgeon working — and their rough size.
   • Read a Medicare versus Medicaid reimbursement table and see why payer mix matters.
   • Compare subspecialties by salary, work RVUs, and dollars per RVU — and explain why they diverge.

   Takeaway: Here's the P&L to carry with you. A single neurosurgeon costs roughly two hundred fifty to five hundred thousand dollars a year to keep working. In an illustrative model, one-point-two million in collections minus about four hundred twenty-five thousand in expenses leaves around seven hundred seventy-five thousand in net salary — almost exactly the highest average Doximity reported. Reimbursement is falling and uneven: Medicaid pays a fraction of Medicare for the same operation, and volume is not the same as value. That profit number — what's left in the gold bar — is the single figure every private-equity offer is built on. Learn to read it, and the deal math ahead becomes simple arithmetic.

3. Lesson 3: Consolidation: Why Independents Disappear: The Data Behind the Shrinking Independent Practice (22 min)

   • Cite the AMA data on the decline of physician-owned practice and the rise of very large organizations.
   • Describe the practice-size shift in neurosurgery — small groups shrinking, 1,000+ organizations surging.
   • Name the largest physician owners and the difference between vertical and horizontal consolidation.
   • Weigh consolidation honestly: salary security and fewer headaches against lost autonomy.

   Takeaway: The independent practice isn't disappearing by accident — the data shows it. Physician ownership fell from 54% to 49.1% in two years, the fastest drop the AMA has measured, while in neurosurgery the smallest practices shrank and thousand-physician organizations more than doubled their share. A handful of giants now own tens of thousands of physicians each. Consolidation buys real things — salary security, fewer operational headaches, more referrals — and costs a real thing: your autonomy. Knowing which way that trade falls for you starts with knowing the numbers.

4. Lesson 4: Out-of-Network & the No Surprises Act: How Surprise Billing, Private Equity, and the Law Collided (22 min)

   • Explain out-of-network billing, balance bills, and what the No Surprises Act changed in 2022.
   • Name the three mega-deals — HCA, Envision, Team Health — and the private-equity firms behind them.
   • Connect private equity's strategy to the surprise-billing crisis and the law that followed.

   Takeaway: Out-of-network billing is ordinary and legal — the crisis was the surprise: patients with no choice, billed at full freight in an emergency. That crisis was driven heavily by private equity. Three of the decade's largest deals — HCA at thirty-three billion, Envision at eleven-point-three, Team Health at six-point-one — converted emergency physician services to out-of-network and raised fees. A twenty-eight-million-dollar campaign couldn't stop the No Surprises Act, and the law rightly protected patients. But the dispute moved to arbitration, and in my view the physician — not the firm — absorbed the worst of it.

5. Lesson 5: What Private Equity Actually Is: Funds, Capital Tiers, and the Buy-Grow-Sell Cycle (22 min)

   • Define a private-equity fund — who finances it, what it buys, and what 'management control' means.
   • Distinguish the capital tiers — small, medium, and large funds — and how each sells up to the next.
   • Describe the buy-grow-sell cycle and the scale of private equity's move into healthcare.

   Takeaway: Private equity isn't a villain or a savior — it's a structure. A fund pools money from outside investors, institutions, banks, and the firm's own members, then buys businesses to control, grow, and sell. The funds come in tiers — small at five to fifty million, medium at fifty to five hundred, large above that — and each rung sells up to the next, with purchases financed largely by outside banks. Point that machine at medicine and the numbers explode: deals up more than 250% in a decade, value up 187% to $42.6 billion, eighteen percent of all PE deals worldwide. Once you can see the machine, the deal stops being a mystery.

6. Lesson 6: Anatomy of a PE Deal: The Five Players, EBITDA, the Scrape, and the Payout (24 min)

   • Name the five players in a PE deal and what each one is paid to do.
   • Define EBITDA and the 'scrape,' and compute the EBITDA the offer is based on.
   • Walk a deal from the gross payout down to the net cash each surgeon actually receives.

   Takeaway: This is the heart of it. Five players sit at the table, and four of them are paid out of your deal. The price is a multiple of EBITDA, and EBITDA is manufactured by scraping a slice of your own salary and relabeling it as profit. The headline was nine million dollars; after the broker, the bank, the lawyers, the forty-percent MSO reinvestment, and a twenty-three-percent capital-gains tax, the surgeons netted about three-point-six million — and accepted a thirty-percent pay cut, a ten-year contract, and a personal guarantee to get it. None of that is hidden. But you only see it if you can follow the math. Now you can.

7. Lesson 7: The MSO & 'Friendly PC' Model: Management Companies, Corporate Practice of Medicine, and Personal Guarantees (22 min)

   • Explain what an MSO is and why PE builds a hub-and-spoke of practices around it.
   • Describe the 'friendly PC' model and how it sidesteps the Corporate Practice of Medicine Statute.
   • Trace where the money and control go — the 40% MSO equity, the 10-year agreement, and the personal guarantee.

   Takeaway: The MSO-and-friendly-PC structure is the real deal — not the check. The MSO is a genuine platform for scale and efficiency, and the friendly PC is a legal workaround that lets a company control a practice the law says it can't own outright. But the same structure quietly transfers control and risk: about forty percent of your payout rolls back as MSO equity, you sign a ten-year agreement at a reduced salary, you pay a management fee that never falls, and in most deals you personally guarantee the note. Sign nothing until you understand all four.

8. Lesson 8: When Deals Go Wrong — and When They Help: The Four Failure Modes, and the Cases That Worked (22 min)

   • Name the four structural failure modes and explain the mechanism behind each.
   • Cite the CareMore and Oak Street figures as documented examples of deals that helped patients.
   • Weigh both honestly — and understand why more outcome data are still needed.

   Takeaway: When these deals fail, they fail in four predictable ways: no liquidity event within five years; an MSO that can't grow; a salary that falls while the management fee never does; and a loan you personally guaranteed. When they succeed, they can succeed like CareMore — four to twenty-seven centers, twenty-two to fifty-five thousand patients, quality up — or like Oak Street, with fewer admissions, readmissions, and ED visits, and no adverse outcomes. Same model, opposite results. Private equity is not the solution for healthcare — but some deals truly helped patients. Structure and people decide which side you land on, so judge the deal, never the label.

9. Lesson 9: Staying Independent: Levers for Success: Know Your Data, Value-Based Contracts, Lean Operations, and ASCs (20 min)

   • Use your own practice data — payer mix, costs, and outcomes — as the foundation for every independence decision.
   • Identify the operational levers that protect margin: right-sized staffing ratios, ancillary and ASC capture, and value-based contracts.
   • Build the leverage and infrastructure to compete with consolidated groups on your own terms.

   Takeaway: Staying independent is a choice you can earn. The foundation is knowing your data better than any buyer would. On top of it sit three levers: value-based contracts grounded in real outcomes — remembering Fenton's caution that satisfaction alone is not a pure good; a lean structure that resists the cost cliff past seven providers and the drift toward a four-to-one staffing ratio; and ancillary revenue from owning a piece of an ambulatory surgery center, a market heading toward fifty-nine billion dollars. Everything private equity offers to build, you can build — and keep.

10. Lesson 10: The Path Forward — Your Decision Framework: Independent, Hospital, or Private Equity — Deciding with Data (24 min)

    • Compare the three paths — independent, hospital-employed, and private-equity — against your own goals and risk tolerance.
    • Apply a six-question framework (including the personal guarantee) to evaluate any deal on your desk.
    • Leave with concrete next steps to assess, negotiate, or walk away from an offer.

    Takeaway: Three doors stand in front of the independent physician — stay independent, join a hospital, or take a private-equity deal — and each one trades autonomy, security, and money in different proportions. My honest view is that private equity is not the solution for healthcare and that private practice is worth preserving for its autonomy and its freedom to innovate. But the decision is yours, and it has to rest on your data — your P&L, your runway, the scrape, the multiple, the guarantee, and your own appetite for autonomy versus security — not on hype, and not on fear.

Related guides

• Should Physicians Sell Their Practice to Private Equity
• How a Private Equity Healthcare Deal Actually Works